Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors.

Amata E, Marrazzo A, Dichiara M, Modica MN, Salerno L, Prezzavento O, Nastasi G, Rescifina A, Romeo G, Pittalà V.

Data Brief. 2017 Sep 21;15:281-299. doi: 10.1016/j.dib.2017.09.036. eCollection 2017 Dec.

2.

Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors.

Amata E, Marrazzo A, Dichiara M, Modica MN, Salerno L, Prezzavento O, Nastasi G, Rescifina A, Romeo G, Pittalà V.

ChemMedChem. 2017 Nov 22;12(22):1873-1881. doi: 10.1002/cmdc.201700321. Epub 2017 Aug 9.

PMID:
28708269
3.

Sigma-2 receptor ligands QSAR model dataset.

Rescifina A, Floresta G, Marrazzo A, Parenti C, Prezzavento O, Nastasi G, Dichiara M, Amata E.

Data Brief. 2017 Jun 16;13:514-535. doi: 10.1016/j.dib.2017.06.022. eCollection 2017 Aug.

4.

Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis.

Rescifina A, Floresta G, Marrazzo A, Parenti C, Prezzavento O, Nastasi G, Dichiara M, Amata E.

Eur J Pharm Sci. 2017 Aug 30;106:94-101. doi: 10.1016/j.ejps.2017.05.061. Epub 2017 May 29.

PMID:
28571781
5.

S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands.

Nastasi G, Miceli C, Pittalà V, Modica MN, Prezzavento O, Romeo G, Rescifina A, Marrazzo A, Amata E.

J Cheminform. 2017 Jan 21;9:3. doi: 10.1186/s13321-017-0191-5. eCollection 2017.

6.

In vivo confinement promotes collective migration of neural crest cells.

Szabó A, Melchionda M, Nastasi G, Woods ML, Campo S, Perris R, Mayor R.

J Cell Biol. 2016 Jun 6;213(5):543-55. doi: 10.1083/jcb.201602083. Epub 2016 May 30.

7.

Inhibition of the hyaluronan oligosaccharides inflammatory response: reduction of adenosine 2A receptor activation by EPAC and PKA.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Cell Biochem Funct. 2014 Dec;32(8):692-701. doi: 10.1002/cbf.3073. Epub 2014 Nov 4.

PMID:
25367782
8.

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

Passalacqua R, Caminiti C, Buti S, Porta C, Camisa R, Braglia L, Tomasello G, Vaglio A, Labianca R, Rondini E, Sabbatini R, Nastasi G, Artioli F, Prati A, Potenzoni M, Pezzuolo D, Oliva E, Alberici F, Buzio C; POLAR-01 Trial Investigators.

J Immunother. 2014 Nov-Dec;37(9):440-7. doi: 10.1097/CJI.0000000000000055. Erratum in: J Immunother. 2015 Jun;38(5):216.

PMID:
25304727
9.

The SOD mimic MnTM-2-PyP(5+) reduces hyaluronan degradation-induced inflammation in mouse articular chondrocytes stimulated with Fe (II) plus ascorbate.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Nastasi G, Micali A, Puzzolo D, Pisani A, Calatroni A, Campo S.

Int J Biochem Cell Biol. 2013 Aug;45(8):1610-9. doi: 10.1016/j.biocel.2013.05.007. Epub 2013 May 18.

PMID:
23692848
10.

4-mer hyaluronan oligosaccharides stimulate inflammation response in synovial fibroblasts in part via TAK-1 and in part via p38-MAPK.

Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Curr Med Chem. 2013;20(9):1162-72.

PMID:
23298137
11.

Combined treatment with hyaluronan inhibitor Pep-1 and a selective adenosine A2 receptor agonist reduces inflammation in experimental arthritis.

Campo GM, Avenoso A, D'Ascola A, Nastasi G, Micali A, Puzzolo D, Pisani A, Prestipino V, Scuruchi M, Calatroni A, Campo S.

Innate Immun. 2013 Oct;19(5):462-78. doi: 10.1177/1753425912470391. Epub 2013 Jan 2.

PMID:
23283732
12.

Streptococcus bovis endocarditis and colon cancer: myth or reality? A case report and literature review.

Galdy S, Nastasi G.

BMJ Case Rep. 2012 Dec 5;2012. pii: bcr2012006961. doi: 10.1136/bcr-2012-006961. Review.

13.

Protein kinase a mediated anti-inflammatory effects exerted by adenosine treatment in mouse chondrocytes stimulated with IL-1β.

Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Biofactors. 2012 Nov-Dec;38(6):429-39. doi: 10.1002/biof.1040. Epub 2012 Oct 25.

PMID:
23097357
14.

The stimulation of adenosine 2A receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides.

Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Matrix Biol. 2012 Jul;31(6):338-51. doi: 10.1016/j.matbio.2012.07.001. Epub 2012 Jul 13.

PMID:
22796382
15.

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.

Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, Ramat S, Ceravolo MG, Meco G, Cicarelli G, Pederzoli M, Manfredi M, Ceravolo R, Mucchiut M, Volpe G, Abbruzzese G, Bottacchi E, Bartolomei L, Ciacci G, Cannas A, Randisi MG, Petrone A, Baratti M, Toni V, Cossu G, Del Dotto P, Bentivoglio AR, Abrignani M, Scala R, Pennisi F, Quatrale R, Gaglio RM, Nicoletti A, Perini M, Avarello T, Pisani A, Scaglioni A, Martinelli PE, Iemolo F, Ferigo L, Simone P, Soliveri P, Troianiello B, Consoli D, Mauro A, Lopiano L, Nastasi G, Colosimo C.

J Neurol. 2012 Dec;259(12):2621-31. doi: 10.1007/s00415-012-6557-8. Epub 2012 Jun 19.

PMID:
22711157
16.

Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1β.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Nastasi G, Calatroni A, Campo S.

FEBS J. 2012 Jun;279(12):2120-33. doi: 10.1111/j.1742-4658.2012.08598.x. Epub 2012 May 9.

17.

Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes.

Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Biofactors. 2012 Jan-Feb;38(1):69-76. doi: 10.1002/biof.202. Epub 2012 Jan 30.

PMID:
22287316
18.

The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis.

Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Nastasi G, Calatroni A, Campo S.

J Cell Biochem. 2012 Jun;113(6):1852-67. doi: 10.1002/jcb.24054.

PMID:
22234777
19.

Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collagen-induced arthritis.

Campo GM, Avenoso A, D'Ascola A, Prestipino V, Scuruchi M, Nastasi G, Calatroni A, Campo S.

Arch Biochem Biophys. 2012 Feb 1;518(1):42-52. doi: 10.1016/j.abb.2011.12.005. Epub 2011 Dec 14.

PMID:
22197458
20.

Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(₂A) receptor.

Bitto A, Polito F, Irrera N, D'Ascola A, Avenoso A, Nastasi G, Campo GM, Micali A, Bagnato G, Minutoli L, Marini H, Rinaldi M, Squadrito F, Altavilla D.

Arthritis Rheum. 2011 Nov;63(11):3364-71. doi: 10.1002/art.30538.

21.

Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression.

Campo GM, Avenoso A, Nastasi G, Micali A, Prestipino V, Vaccaro M, D'Ascola A, Calatroni A, Campo S.

Biochim Biophys Acta. 2011 Sep;1812(9):1170-81. doi: 10.1016/j.bbadis.2011.06.006. Epub 2011 Jun 21.

22.

High-molecular weight hyaluronan reduced renal PKC activation in genetically diabetic mice.

Campo GM, Avenoso A, Micali A, Nastasi G, Squadrito F, Altavilla D, Bitto A, Polito F, Rinaldi MG, Calatroni A, D'Ascola A, Campo S.

Biochim Biophys Acta. 2010 Nov;1802(11):1118-30. doi: 10.1016/j.bbadis.2010.08.004. Epub 2010 Aug 13.

23.

Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes.

Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A.

Biochem Pharmacol. 2010 Aug 15;80(4):480-90. doi: 10.1016/j.bcp.2010.04.024. Epub 2010 May 8.

PMID:
20435021
24.

Molecular cloning and characterization of adult Sparus aurata hemoglobin genes.

Campo S, Nastasi G, Fedeli D, D'Ascola A, Campo GM, Avenoso A, Ferlazzo A, Calatroni A, Falcioni G.

OMICS. 2010 Apr;14(2):187-200. doi: 10.1089/omi.2009.0098.

PMID:
20210659
25.

Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes.

Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A.

Biochimie. 2010 Feb;92(2):204-15. doi: 10.1016/j.biochi.2009.10.006. Epub 2009 Oct 29.

PMID:
19879319
26.

The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation.

Campo GM, Avenoso A, Campo S, Nastasi G, Traina P, D'Ascola A, Rugolo CA, Calatroni A.

Br J Pharmacol. 2008 Nov;155(6):945-56. doi: 10.1038/bjp.2008.338. Epub 2008 Aug 25.

27.

Characterization of phospholipid composition of pig plasma and erythrocyte membranes.

Bruschetta G, Alberghina D, Nastasi G, Rotondo E, Ferlazzo AM.

Vet Res Commun. 2008 Sep;32 Suppl 1:S115-8. doi: 10.1007/s11259-008-9101-7. No abstract available.

PMID:
18685996
28.

Hemoglobin system of Sparus aurata: changes in fishes farmed under extreme conditions.

Campo S, Nastasi G, D'Ascola A, Campo GM, Avenoso A, Traina P, Calatroni A, Burrascano E, Ferlazzo A, Lupidi G, Gabbianelli R, Falcioni G.

Sci Total Environ. 2008 Sep 15;403(1-3):148-53. doi: 10.1016/j.scitotenv.2008.05.027. Epub 2008 Jun 27.

PMID:
18585756
29.

Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.

Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M, Sabbatini G, Endrizzi L, Marra A, Aitini E, Calorio A, Garetto F, Nastasi G, Piantedosi F, Sidoti V, Spanu P.

Clin Drug Investig. 2008;28(7):399-407.

PMID:
18544000
30.

Chondroitin-4-sulphate reduced oxidative injury in caerulein-induced pancreatitis in mice: the involvement of NF-kappaB translocation and apoptosis activation.

Campo GM, Avenoso A, Campo S, Nastasi G, Traina P, D'Ascola A, Calatroni A.

Exp Biol Med (Maywood). 2008 Jun;233(6):741-52. doi: 10.3181/0711-RM-318. Epub 2008 Apr 11.

PMID:
18408139
31.

On-site screening and GC-MS analysis of cocaine and heroin metabolites in body-packers urine.

Marchei E, Colone P, Nastasi GG, Calabrò C, Pellegrini M, Pacifici R, Zuccaro P, Pichini S.

J Pharm Biomed Anal. 2008 Sep 29;48(2):383-7. doi: 10.1016/j.jpba.2007.11.025. Epub 2007 Nov 26.

PMID:
18164159
32.

Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer.

Riccardi A, Brugnatelli S, Giordano M, Danova M, Pugliese P, Tinelli C, Klersy C, Richetti A, Fava S, Nastasi G, Rinaldi E, Fregoni V, De Monte A, Trotti G, Bovio A, Ascari E.

Tumori. 1998 Sep-Oct;84(5):540-6.

PMID:
9862513
33.

Atrial septal aneurysm in a patient with pseudoxanthoma elasticum.

Bertulezzi G, Paris R, Moroni M, Porta C, Nastasi G, Amadeo A.

Acta Cardiol. 1998;53(4):223-5.

PMID:
9842408
34.

Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.

Porta C, Moroni M, Ferrari S, Nastasi G.

Neoplasma. 1998;45(2):81-2.

PMID:
9687887
35.

Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system.

Alessiani M, Vai L, Jemos V, Dionigi P, Spada M, Porta C, Moroni M, Nastasi G, Fossati GS, Zonta A.

Hepatogastroenterology. 1998 Jan-Feb;45(19):206-8.

PMID:
9496514
36.

Jaw bone metastasis from hepatocellular carcinoma.

Zanirato S, Porta C, Moroni M, Nastasi G.

Ital J Gastroenterol Hepatol. 1997 Oct;29(5):478-9. No abstract available.

PMID:
9494862
37.

Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study.

Bobbio-Pallavicini E, Porta C, Moroni M, Bertulezzi G, Civelli L, Pugliese P, Nastasi G.

Eur J Cancer. 1997 Oct;33(11):1784-8.

PMID:
9470833
38.

Endodermal sinus tumor of the ovary in pregnancy.

Bognoni V, Quartuccio A, Nastasi G, Riso S, Moroni M, Porta C.

Oncol Rep. 1997 May-Jun;4(3):599-601.

PMID:
21590106
39.

Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients.

Nastasi G, Porta C, Moroni M, Alessiani M, Fossati G.

Oncol Rep. 1997 May-Jun;4(3):511-4.

PMID:
21590087
40.

Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients.

Moroni M, Porta C, Gualtieri G, Nastasi G, Tinelli C.

Br J Cancer. 1996 Jul;74(2):309-11.

42.
43.
44.

A search for double minute chromosomes in cultured lymphocytes from different types of tumors.

Scappaticci S, Fossati GS, Valenti L, Scabini M, Tateo S, Nastasi G, Spina MP, Capra E.

Cancer Genet Cytogenet. 1995 Jul 1;82(1):50-3.

PMID:
7627934
45.

Utility of embolization of chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma.

Porta C, Moroni M, Nastasi G, Bobbio-Pallavicini E, Barazzoni G.

Cancer. 1995 Jun 1;75(11):2782-4. No abstract available.

PMID:
7743488
46.

[Hypokalemic rhabdomyolysis and thiazide diuretics. 3 clinical cases].

Girola SS, Mazzone A, Moroni M, Porta C, Nastasi G, Notario A.

Ann Ital Med Int. 1995 Apr-Jun;10(2):134-7. Italian.

PMID:
7619654
48.
49.

Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis.

Porta C, Moroni M, Nastasi G.

Am J Clin Oncol. 1994 Jun;17(3):246-7.

PMID:
8192112
50.

Nephrectomy as a component of systemic treatment for renal cell carcinoma patients.

Nastasi G, Porta C, Moroni M, Bobbio-Pallavicini E, Santagati G, Santagati C, Alessiani M.

J Surg Oncol. 1994 Jun;56(2):81-2. No abstract available.

PMID:
8007683

Supplemental Content

Loading ...
Support Center